Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autotransplants: now and in the future.

R P Gale1, J O Armitage, K A Dicke

  • 1Department of Medicine, UCLA School of Medicine 90024-1678.

Bone Marrow Transplantation
|February 1, 1991
PubMed
Summary

Autotransplant therapy shows consistent 3-year disease-free survival in advanced cancers, suggesting dose escalation limits. Optimal timing and patient selection require further study to maximize patient benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral T-Cell Lymphoma-A Brief Review.

Leukemia & lymphoma·2016
Same author

Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.

Expert opinion on biological therapy·2015
Same author

Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).

Bone marrow transplantation·2012
Same author

Chromosomal abnormalities in malignant lymphoma and Hodgkin's disease.

Leukemia & lymphoma·2011
Same author

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Stromal gene signatures in large-B-cell lymphomas.

The New England journal of medicine·2008

Area of Science:

  • Hematology-Oncology
  • Cancer Therapeutics
  • Clinical Trials

Background:

  • Autotransplant therapy demonstrates a consistent 3-year disease-free survival rate of approximately 20% in advanced lymphomas and solid tumors, irrespective of diagnosis.
  • This consistency raises questions about the efficacy of dose escalation beyond a certain point and the potential for increased toxicity.
  • The observed outcomes must be carefully evaluated to rule out biases from subject selection or treatment timing, ensuring genuine patient benefit.

Purpose of the Study:

  • To investigate the reasons behind the consistent autotransplant outcomes across different advanced cancers.
  • To explore the concept of 'optimal' timing for autotransplants and its impact on patient selection and overall results.
  • To highlight the need for controlled studies to validate the efficacy of autotransplants in various cancer settings.

Main Methods:

  • Review of existing autotransplant data in lymphomas and solid tumors.
  • Analysis of prognostic factors influencing autotransplant outcomes.
  • Discussion of potential biases in patient selection and treatment timing.
  • Identification of the need for controlled and randomized trials.

Main Results:

  • Autotransplant results show a similar 3-year disease-free survival rate (around 20%) in advanced lymphomas and solid tumors.
  • Prognostic factors for autotransplant success appear similar to those for chemotherapy.
  • There is a risk that selecting 'best' candidates for autotransplants may exclude patients who could benefit most.

Conclusions:

  • The consistent survival rates may indicate a plateau in achievable cures via dose escalation, with diminishing returns and increased toxicity.
  • Careful consideration of patient selection and treatment timing is crucial to balance improved outcomes with rescuing the maximum number of patients.
  • Further randomized controlled trials are essential to definitively establish the efficacy of autotransplants in various cancer types and disease stages.

Related Experiment Videos